Jesse C. Nussbaum

5.6k total citations · 4 hit papers
32 papers, 4.2k citations indexed

About

Jesse C. Nussbaum is a scholar working on Immunology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jesse C. Nussbaum has authored 32 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jesse C. Nussbaum's work include IL-33, ST2, and ILC Pathways (10 papers), Eosinophilic Esophagitis (8 papers) and Immune Cell Function and Interaction (8 papers). Jesse C. Nussbaum is often cited by papers focused on IL-33, ST2, and ILC Pathways (10 papers), Eosinophilic Esophagitis (8 papers) and Immune Cell Function and Interaction (8 papers). Jesse C. Nussbaum collaborates with scholars based in United States, United Kingdom and Switzerland. Jesse C. Nussbaum's co-authors include Richard M. Locksley, Ari B. Molofsky, Hong-Erh Liang, Steven J. Van Dyken, Ajay Chawla, Alexander Mohapatra, Laurence E. Cheng, Jinwoo Lee, Emily Thornton and Matthew F. Krummel and has published in prestigious journals such as Nature, Cell and The Journal of Experimental Medicine.

In The Last Decade

Jesse C. Nussbaum

32 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 innate lymphoid cells control eosinophil homeostasis

2013 831 citations Jesse C. Nussbaum, Steven J. Van Dyken et al. profile →
Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

2013 712 citations Ari B. Molofsky, Jesse C. Nussbaum et al. profile →
Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis

2014 543 citations Ari B. Molofsky, Jesse C. Nussbaum et al. profile →
Tissue signals imprint ILC2 identity with anticipatory function

2018 327 citations Roberto R. Ricardo-González, Steven J. Van Dyken et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesse C. Nussbaum United States	15	2.9k	1.7k	1.2k	997	371	32	4.2k
Steven J. Van Dyken United States	24	3.2k 1.1×	1.7k 1.0×	1.2k 1.0×	538 0.5×	171 0.5×	42	4.5k
Habib Zaghouani United States	26	2.2k 0.8×	362 0.2×	300 0.3×	487 0.5×	227 0.6×	99	3.5k
Yohei Mikami Japan	30	1.5k 0.5×	642 0.4×	292 0.2×	508 0.5×	258 0.7×	95	3.4k
Hajime Suto Japan	31	2.5k 0.9×	569 0.3×	1.4k 1.2×	550 0.6×	93 0.3×	58	4.6k
Steven A. Saenz United States	17	3.3k 1.1×	1.6k 0.9×	1.4k 1.2×	402 0.4×	113 0.3×	18	4.4k
Corrado Cilio Sweden	38	1.2k 0.4×	1.1k 0.6×	201 0.2×	316 0.3×	148 0.4×	88	3.9k
Lidia Bosurgi Germany	22	2.1k 0.7×	441 0.3×	339 0.3×	346 0.3×	358 1.0×	34	3.6k
Milena Bogunovic United States	23	4.5k 1.6×	596 0.3×	479 0.4×	349 0.4×	255 0.7×	30	6.0k
Sebastian Reuter Germany	25	1.5k 0.5×	762 0.4×	811 0.7×	165 0.2×	134 0.4×	62	2.8k
Valérie Quesniaux France	24	1.4k 0.5×	272 0.2×	673 0.6×	341 0.3×	357 1.0×	39	2.8k

Countries citing papers authored by Jesse C. Nussbaum

Since Specialization

Citations

This map shows the geographic impact of Jesse C. Nussbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse C. Nussbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse C. Nussbaum more than expected).

Fields of papers citing papers by Jesse C. Nussbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse C. Nussbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse C. Nussbaum. The network helps show where Jesse C. Nussbaum may publish in the future.

Co-authorship network of co-authors of Jesse C. Nussbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse C. Nussbaum. A scholar is included among the top collaborators of Jesse C. Nussbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse C. Nussbaum. Jesse C. Nussbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwasa, Takashi, et al.. (2024). Clinical Pharmacology Strategy for Registration in Japan with a Case Example of Posaconazole, a Globally Approved Triazole Antifungal Drug with Broad-spectrum Antifungal Activity. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 55(3). 99–113. 1 indexed citations

Robbins, Jonathan A., Scott A. Sands, Tami Crumley, et al.. (2024). Gefapixant as a P2X3 receptor antagonist treatment for obstructive sleep apnea: a randomized controlled trial. Journal of Clinical Sleep Medicine. 20(12). 1905–1913. 4 indexed citations

Nussbaum, Jesse C., Azher Hussain, P. Butera, et al.. (2024). Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, in Healthy Adults. The Journal of Clinical Pharmacology. 64(8). 1023–1029. 4 indexed citations

Nussbaum, Jesse C., Radha Railkar, Jeffrey R. Sachs, et al.. (2023). Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults. Vaccine. 41(44). 6488–6501. 12 indexed citations

Pruimboom‐Brees, Ingrid, Swati Gupta, Nagendra Chemuturi, et al.. (2023). International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs. Clinical and Translational Science. 16(5). 723–741. 6 indexed citations

Walford, Geoffrey, An Bautmans, Kelly Duncan, et al.. (2023). Considerations for Cell and Gene Therapy Programs Entering the Clinical Space. Clinical Pharmacology & Therapeutics. 114(3). 569–577. 4 indexed citations

Sanchez, Lauren, et al.. (2023). Transition of care in inborn errors of immunity: Outcomes of a single-center quality improvement initiative. The Journal of Allergy and Clinical Immunology In Practice. 11(7). 2245–2247.e1. 2 indexed citations

Chawla, Akshita, Azher Hussain, Huub Jan Kleijn, et al.. (2023). Population pharmacokinetic analysis of the P2X3‐receptor antagonist gefapixant. CPT Pharmacometrics & Systems Pharmacology. 12(8). 1107–1118. 5 indexed citations

Nussbaum, Jesse C., Azher Hussain, Anthony Ford, et al.. (2022). A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults. Lung. 200(3). 315–323. 1 indexed citations

10.

Schneider, Christoph, Jinwoo Lee, Satoshi Koga, et al.. (2019). Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal Priming. Immunity. 50(6). 1425–1438.e5. 185 indexed citations

11.

Levinson, Warren, Peter Chin‐Hong, Elizabeth A. Joyce, Jesse C. Nussbaum, & Brian Schwartz. (2018). Review of medical microbiology and immunology : a guide to clinical infectious diseases. 3 indexed citations

12.

Ricardo-González, Roberto R., Steven J. Van Dyken, Christoph Schneider, et al.. (2018). Tissue signals imprint ILC2 identity with anticipatory function. Nature Immunology. 19(10). 1093–1099. 327 indexed citations breakdown →

13.

Dyken, Steven J. Van, Jesse C. Nussbaum, Jinwoo Lee, et al.. (2016). A tissue checkpoint regulates type 2 immunity. Nature Immunology. 17(12). 1381–1387. 192 indexed citations

14.

Mohapatra, Alexander, et al.. (2015). Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunology. 9(1). 275–286. 167 indexed citations

15.

Wang, Yongmei, Kirk D. Jones, Jesse C. Nussbaum, et al.. (2015). A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting. Calcified Tissue International. 97(6). 634–639. 13 indexed citations

16.

Molofsky, Ari B., Frédéric Van Gool, Hong-Erh Liang, et al.. (2015). Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity. 43(1). 161–174. 347 indexed citations

17.

Dyken, Steven J. Van, Alexander Mohapatra, Jesse C. Nussbaum, et al.. (2014). Chitin Activates Parallel Immune Modules that Direct Distinct Inflammatory Responses via Innate Lymphoid Type 2 and γδ T Cells. Immunity. 40(3). 414–424. 204 indexed citations

18.

Nussbaum, Jesse C., Arthur Jackson, Dan Namarika, et al.. (2009). Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in Malawi. Clinical Infectious Diseases. 50(3). 338–344. 138 indexed citations

19.

Liu, Limin, et al.. (2003). Enzymes that Counteract Nitrosative Stress Promote Fungal Virulence. Current Biology. 13(22). 1963–1968. 134 indexed citations

20.

Touchman, Jeffrey W., Gerard G. Bouffard, Lauren Weintraub, et al.. (1997). 2006 expressed-sequence tags derived from human chromosome 7-enriched cDNA libraries.. Genome Research. 7(3). 281–292. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact